| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $36K | -41.0% |
| R&D Expense | $158.7M | -7.5% |
| SG&A Expense | $45.1M | -13.3% |
| Operating Income | -$269.4M | +24.9% |
| Income Tax | $0 | — |
| Net Income | -$274.4M | +20.0% |
| EPS (Basic) | -$16.06 | -1126.0% |
| EPS (Diluted) | -$16.06 | -1126.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.2M | -43.0% |
| Short-term Investments | $187.0M | -29.4% |
| Current Assets | $260.9M | -31.3% |
| Total Assets | $340.1M | -30.7% |
| Current Liabilities | $49.4M | -8.1% |
| Total Liabilities | $91.8M | -15.0% |
| Stockholders' Equity | $248.2M | -35.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$150.0M | +7.6% |
| Capital Expenditures | $780K | +68.1% |
| Investing Cash Flow | $54.1M | -55.8% |
| Financing Cash Flow | $50.4M | +3701.4% |
| Free Cash Flow | -$150.8M | +7.4% |